Recent Finacing
Recent Raise
Teitur Trophics develops circular-peptide therapeutics for neurodegenerative diseases, advancing lead candidate TT-P34—designed to clear toxic protein deposits and restore mitochondrial function—into Phase 1b clinical development in Aarhus, Denmark.
